Zihan Ling

Dr. Zihan Ling

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
BVBarbie Varghese
Barbie Varghese
ZLZihan Ling
Zihan Ling
XRXi Ren
Xi Ren
The global burden of pulmonary disease highlights an overwhelming need in improving our understanding of lung development, disease, and treatment. It also calls for further advances in our ability to engineer the pulmonary system at cellular and tissue levels. The discovery of human pluripotent stem cells (hPSCs) offsets the relative inaccessibility of human lungs for studying developmental programs and disease mechanisms, all the while offering a potential source of cells and tissue for regenerative interventions. This review offers a perspective on where the lung stem cell field stands in terms of accomplishing these ambitious goals. We will trace the known stages and pathways involved in in vivo lung development and how they inspire the directed differentiation of stem and progenitor cells in vitro.We will also recap the efforts made to date to recapitulate the lung stem cell niche in vitro via engineered cell–cell and cell-extracellular matrix (ECM) interactions.

4 May 2021 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
YXYunhui Xing
Yunhui Xing
BVBarbie Varghese
Barbie Varghese
ZLZihan Ling
Zihan Ling
AKAnanya Sushanta Kar
Ananya Sushanta Kar
EJEmily Reinoso Jacome
Emily Reinoso Jacome
XRXi Ren
Xi Ren

1 January 2021 in Bio-Protocol
Verified
Journal Article
Closed access
PDF file
EJEmily Reinoso Jacome
Emily Reinoso Jacome
ZLZihan Ling
Zihan Ling
YXYunhui Xing
Yunhui Xing
SFShierly W. Fok
Shierly W. Fok
XRXi Ren
Xi Ren
Decellularized extracellular matrix (ECM) biomaterials derived from native tissues and organs are widely used for tissue engineering and wound repair. To boost their regenerative potential, ECM biomaterials can be functionalized via the immobilization of bioactive molecules. To enable ECM functionalization in a chemoselective manner, we have recently reported an effective approach for labeling native organ ECM with the click chemistry-reactive azide ligand via physiologic post-translational glycosylation. Here, using the rat lung as a model, we provide a detailed protocol for in vivo and ex vivo metabolic azide labeling of the native organ ECM using N-Azidoacetylgalactosamine-tetraacylated (Ac4GalNAz), together with procedures for decellularization and labeling characterization. Our approach enables specific and robust ECM labeling within three days in vivo or within one day during ex vivo organ culture. The resulting ECM labeling remains stable following decellularization. With our approach, ECM biomaterials can be functionalized with desired alkyne-modified biomolecules, such as growth factors and glycosaminoglycans, for tissue engineering and regenerative applications. Bio-protocol is an online peer-reviewed protocol journal. Its mission is to make life science research more efficient and reproducible by curating and hosting high quality, free access protocols.

6 September 2025 in Advanced Materials
Verified
Journal Article
Open access
ZLZihan Ling
Zihan Ling
BNBurke Niego
Burke Niego
QLQingyang Li
Qingyang Li
DBDhruv Bhattaram
Dhruv Bhattaram
VVVanessa Serna Villa
Vanessa Serna Villa
XRXi Ren
Xi Ren
In both native and engineered tissues, the extracellular matrix (ECM) supports and regulates nearly all aspects of cellular pathophysiology, and in response, cells extensively remodel their surrounding extracellular environments through new ECM protein deposition. Understanding this intricate bi‐directional cell‐ECM interaction is key to tissue engineering, but it remains challenging to investigate. This is partly due to the limited sensitivity of conventional proteomics to capture low‐abundance newly synthesized ECM (newsECM). This study presents a glycosylation‐enabled, chemoselective strategy to label, enrich, and characterize newsECM proteins with augmented specificity and sensitivity. Applying newsECM profiling to bioengineered tumor tissues, either built upon decellularized ECM materials (dECM‐tumor) or as ECM‐free tumoroids, revealed distinct ECM synthesis patterns. Tumor cells cultured within dECM scaffold present elevated ECM remodeling activities, mediated by augmented digestion of pre‐existing ECM coupled with upregulated synthesis of tumor‐associated ECM components. These findings highlight the sensitivity of newsECM profiling to capture remodeling events that are otherwise under‐represented by bulk proteomics and underscore the significance of dECM support for enabling native‐like tumor cell behaviors. The newsECM profiling described here is anticipated to be applicable to a wide range of engineered tissue models and pathophysiological processes to deliver fundamental insights regarding the mutual cell‐ECM crosstalk.

1 July 2023 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
ZLZihan Ling
Zihan Ling
KNKentaro Noda
Kentaro Noda
BFBrian L. Frey
Brian L. Frey
MHMichael Hu
Michael Hu
SFShierly W. Fok
Shierly W. Fok
XRXi Ren
Xi Ren
This study developed and implemented a bioorthogonal strategy to chemoselectively label, enrich, and characterize newly synthesized (NewS-)glycoproteins during 4-h ex vivo lung perfusion (EVLP). Through this approach, the investigators uncovered specific proteomic signatures associated with warm ischemic injury in donor lung grafts. These signatures exhibit high biological relevance to ischemia-reperfusion injury, validating the robustness of the presented approach.

2 November 2025 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
NANeha Atale
Neha Atale
ZLZihan Ling
Zihan Ling
XRXi Ren
Xi Ren
KNKentaro Noda
Kentaro Noda
Pablo G. G SanchezPablo G. G Sanchez
Pablo G. G Sanchez
Background: Developing clinically relevant experimental models of the human airway can significantly advance our understanding of the mechanisms underlying airway diseases and aid in translating potential therapies to clinical settings. The aim of this study is to establish an ex vivo human airway tissue culture model. Methods: Human donor airway tissues were obtained from clinical cases of lung transplantation. Our established method is based on the concept of scavenging metabolic activity and controlling bacterial growth and includes increased media volume, frequent media exchange, and antifungal additives to efficiently maintain the homeostatic culture environment. After a 3-day culture period, the airway was investigated, and its viability and function were compared with a standard cell culture method. Results: Control tissue exhibited significant acidosis after 3 days, suggesting high metabolic activity of airway tissue and bacterial contamination. The airway epithelial viability—after culturing in our established method for 3 days—was better than that of the controls. We only performed an acute but early investigation of the cultures as airway complications have been known to start early at the proximal bronchus after transplantation. H&E and alcian blue staining showed intact morphology of the epithelium of airway tissue and mucus layers after 3 days in our model, while controls showed remarkable damage to the epithelial layer. Newly synthesized glycoproteins were detected in the epithelial layer using metabolic labeling and the click chemistry technique, suggesting cellular protein synthesis of the airway tissue in our established ex vivo model. Conclusions: We successfully established a reproducible model of human ex vivo airway tissue culture (n = 3 independent biological samples) that may be useful for investigating airway complications and developing their therapies.